H.C. Wainwright Remains a Buy on Sangamo Biosciences (SGMO)

In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report), with a price target of $10.00. The company’s shares closed last Friday at $0.73.

Protect Your Portfolio Against Market Uncertainty

• Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
• Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.

Trucchio covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Precision BioSciences, and uniQure. According to TipRanks, Trucchio has an average return of -3.8% and a 31.89% success rate on recommended stocks.

Sangamo Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $5.00.

SGMO market cap is currently $163.7M and has a P/E ratio of -1.41.